[HTML][HTML] Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
X Xu, B Sun, C Zhao - Neurobiology of Disease, 2023 - Elsevier
Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) is the most extensively studied member
of the PARP superfamily, with its primary function being the facilitation of DNA damage …
of the PARP superfamily, with its primary function being the facilitation of DNA damage …
[HTML][HTML] Sex and brain: the role of sex chromosomes and hormones in brain development and parkinson's disease
F Terrin, A Tesoriere, N Plotegher, L Dalla Valle - Cells, 2023 - mdpi.com
Sex hormones and genes on the sex chromosomes are not only key factors in the regulation
of sexual differentiation and reproduction but they are also deeply involved in brain …
of sexual differentiation and reproduction but they are also deeply involved in brain …
[HTML][HTML] Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's …
X Wang, W Hu, L Qu, J Wang, A Wu, HH Lo… - Pharmacological …, 2023 - Elsevier
Tricin, a natural nontoxic flavonoid distributed in grasses and euphorbia plants, has been
reported to scavenge free radicals, possess anti-inflammatory and antioxidative effects …
reported to scavenge free radicals, possess anti-inflammatory and antioxidative effects …
Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition
Background Parkinson's disease (PD) is a neurodegenerative condition characterized by
the progressive loss of dopaminergic neurons within the substantia nigra …
the progressive loss of dopaminergic neurons within the substantia nigra …
[HTML][HTML] Olfactory Dysfunction in Parkinson's Disease, Its Functional and Neuroanatomical Correlates
G Torres-Pasillas, D Chi-Castañeda, P Carrillo-Castilla… - NeuroSci, 2023 - mdpi.com
Parkinson's disease (PD) is known for its motor alterations, but the importance of non-motor
symptoms (NMSs), such as olfactory dysfunction (OD), is increasingly recognized. OD may …
symptoms (NMSs), such as olfactory dysfunction (OD), is increasingly recognized. OD may …
[HTML][HTML] Parkinson's Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disease characterized by the presence of dopaminergic neuronal loss and motor disorders …
disease characterized by the presence of dopaminergic neuronal loss and motor disorders …
[HTML][HTML] Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons
J Yu, Z Zhao, Y Li, J Chen, N Huang, Y Luo - Heliyon, 2024 - cell.com
Parkinson's disease (PD) is a neurodegenerative disorder with motor symptoms like
bradykinesia, tremors, and balance issues. The pathology is recognized by progressively …
bradykinesia, tremors, and balance issues. The pathology is recognized by progressively …
[HTML][HTML] Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February–2 March, 2024 (2024Pdm3)
S Zampieri, I Bersch, P Smeriglio… - European Journal of …, 2024 - ncbi.nlm.nih.gov
Abstract During the 2023 Padua Days on Muscle and Mobility Medicine the 2024 meeting
was scheduled from 28 February to 2 March 2024 (2024Pdm3). During autumn 2023 the …
was scheduled from 28 February to 2 March 2024 (2024Pdm3). During autumn 2023 the …
[HTML][HTML] Five Padua days on muscle and mobility medicine (2024Pdm3) 27 February-2 March, 2024 at Hotel Petrarca, Thermae of Euganean Hills, Padua, and San …
S Zampieri, I Bersch, P Smeriglio… - European Journal of …, 2023 - ncbi.nlm.nih.gov
At the end of the 2023 Padua Days of Muscle and Mobility Medicine the next year's meeting
was scheduled from 27 February to 2 March 2024 (2024Pdm3). During the summer and …
was scheduled from 27 February to 2 March 2024 (2024Pdm3). During the summer and …
Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson's disease
M de Freitas Silva, CJC Ortiz, LF Coelho, L Pruccoli… - Bioorganic …, 2024 - Elsevier
Molecular hybridization between structural fragments from the structures of curcumin (1) and
resveratrol (2) was used as a designing tool to generate a new N-acyl-cinnamoyl-hydrazone …
resveratrol (2) was used as a designing tool to generate a new N-acyl-cinnamoyl-hydrazone …